Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023

SELL
$1.21 - $2.22 $842 - $1,545
-696 Reduced 5.2%
12,700 $17,000
Q4 2022

Feb 02, 2023

BUY
$0.85 - $1.69 $2,360 - $4,693
2,777 Added 26.15%
13,396 $23,000
Q3 2022

Oct 31, 2022

BUY
$2.14 - $3.7 $22,724 - $39,290
10,619 New
10,619 $20,000

Others Institutions Holding PRDS

About PARDES BIOSCIENCES, INC.


  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.